Filing Flows

Filing Flows › Privia Health Group (PRVA) › Q4 2025

Privia Health Group (PRVA) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 27, 2026

Privia Health Group (PRVA) reported revenue of $541M for the fourth quarter 2025 (Q4 2025), +17% from a year earlier and -7% from the quarter before. Operating margin was 2.1%, net earnings $9.2M (1.7% of revenue).

Revenue$541M
Year over year+17%
Quarter over quarter-7%
Operating margin2.1%
Net earnings$9.2M

Privia Health Group, Q4 2025: revenue $541M (+17% year over year), operating margin 2.1%, net earnings $9.2M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$541M-7%+17%
Operating profit$11.3M-22%+115%
Net earnings$9.2M+33%+108%
Operating cash flow$128M+145%+70%

What changed

Revenue was $541.2M in Q4 2025, up 17% year over year and down 7% from the previous quarter. FFS-patient care was the largest line at 67% of revenue.

Operating profit was $11.3M, a 2.1% margin (up 0.9 points year over year). Of the extra revenue versus a year earlier, 8% reached operating profit, above the 1% margin then. Total costs grew 16% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+19%). Net earnings were $9.2M, up 108% year over year. The effective tax rate was 20.8%.

Operating cash flow was $127.5M (up 70% year over year), 1205% of net income including minority interests. Non-cash charges added back $2.7M of depreciation and amortization and $15.5M of share-based compensation. Working capital and other items added $98.8M.

Questions

What was Privia Health Group's revenue in the fourth quarter 2025?

Privia Health Group (PRVA) reported revenue of $541M for the fourth quarter 2025 (Q4 2025), +17% from a year earlier and -7% from the quarter before.

Was Privia Health Group profitable in the fourth quarter 2025?

Operating profit was $11.3M (2.1% of revenue) and net earnings $9.2M.

Open the interactive Sankey →

Source: Privia Health Group 10-K on SEC EDGAR.